Abstract
Some new di and tri-organosilicon complexes of type R2Si(L1)Cl, R3Si(L1), and R2Si(L2)/R2Si(L3) (R = Me, Et, Bu, and Ph; L1 = 4-hydroxy-6-methyl-3-[1-(quinolin-8-ylimino)ethyl]pyran-2-one, L2 = 3-[1-(2-aminophenylimino)ethyl]-4-hydroxy-6-methylpyran-2-one, and L3 = 3-[1-(2-amino-4-chlorophenylimino)ethyl]-4-hydroxy-6-methylpyran-2-one) were synthesized from Schiff base ligands derived from 8-aminoquinoline/o-phenylenediamine/4-chloro-o-phenylenediamine with dehydroacetic acid. All the compounds were characterized with the help of molar conductance measurements, elemental analyses, UV–Vis, IR, 1H, 13C, 29Si NMR, and mass spectroscopy. On the basis of all these studies, penta-coordinated environment around central silicon atom in 1:1 molar ratio was proposed. The ligands and their organosilicon complexes were tested in vitro for antibacterial activity against Gram-positive bacteria viz. Staphylococcus aureus, Bacillus subtilis as well as Gram-negative bacteria viz. Escherichia coli and antifungal activity against Aspergillus niger. Antimicrobial activity results indicated that biological activity of ligands was enhanced on complexation with organosilicon group and phenyl derivatives were found to be more effective antimicrobial agents as compared to other complexes. Further, docking simulation of four compounds against E. coli topoisomerase II DNA gyrase B were carried out.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
